Currently, fetal bovine serum (FBS) 
INTRODUCTION
Serum has been widely used as supplement in cell culture media and it is essential for cell attachment, growth, metabolism and acts as a buffering agent to maintain the pH of cell culture media. The most commonly used serum to support cell growth is derived from animals, mainly from bovine fetus. Fetal bovine serum (FBS) contains components such as proteins, growth factors, trace elements and hormones that are necessary for cell proliferation and maintenance of cells physiology (Valk et al. 2010) . Despite the known advantages of serum in cell culturing media, there are a few drawbacks associated with the use of serum especially from animal sources. First of all, increased utilisation of fetal bovine serum for routine cell culture works worldwide demands more bovine fetuses to be sacrificed and the collection of serum may cause suffering for the unborn calf Valk et al. 2004) . Secondly, fetal bovine serum may also be the possible source of xenogeneic contaminations in cell culture such as contamination of virus and prion. In fact, 20 to 50% of commercial FBS was reported related to virus contamination (Wessman & Levings 1999) . In addition, bovine protein could also attach to cells in culture and acts as antigenic substances that induce immunological reactions during transplantation (Ferdinando & Gaetana 2007) . Thirdly, there are batch to batch variations that compromised the quality of the serum hence testing is necessary to maintain the quality of each batch for cell culture. As a result, phenotypical differences might occur in the cell culture leading to inconsistency of the data or the final products (Valk et al. 2010) . These limitations hinder the clinical application of cells that is cultured in media contain serum and signify the demand of safer and more reliable method to replace the serum. The potential replacement of FBS by stem cells will be discussed in this study.
Stem cells, widely known for their self-renewal and wide differentiation potentials represent a viable alternative for tissue regeneration (Tapp et al. 2009 ). The discovery of stem cells residing in human adipose tissue has drawn attention to the tissue engineering field and offers novel tools to treat various diseases, such as autoimmune-induced diseases (Gonzalez-Rey et al. 2010) , multiple sclerosis (Riordan et al. 2009 ), treatment of fistulas in Crohn's disease (García-Olmo et al. 2005) and potential for microtia repair (Goh et al. 2017) . The initial method to isolate cells from adipose tissue were introduced by Rodbell et al. (1960) and the isolation yielded two populations of cells, the floating mature adipocytes and stromal vascular fractions (SVF). The stromal vascular fraction includes heterogeneous cell population, including preadipocytes, fibroblasts, smooth muscle cells, lymphocytes, macrophages, endothelial cells and adipose derived stem cells (ADSCs). The ADSCs that are isolated from adipose tissue possess high proliferative capability (Zuk et al. 2002) and can undergo various differentiation pathways, including osteogenic (Grottkau & Lin, 2013) , adipogenic (Turner et al. 2017) , chondrogenic (Hamid et al. 2012) , neurogenic (Zhao et al. 2015) , smooth muscle (Salah et al. 2013 ) and insulin-producing cells (Mohamad Buang et al. 2012 ). In addition, ADSCs have been shown to enhance the recovery of injured human hepatocellular carcinoma (HepG2) through secretion of Hepatocyte Growth Factor (HGF) and Vascular Endothelial Growth Factor (VEGF) (Liau et al. 2018) . As one of the most promising stem cells population identified, ADSCs offers two main advantages over other types of stem cells such as bone marrow stem cell and embryonic stem cells. Firstly, ADSCs can be harvested in large quantities with little donor site morbidity during subcutaneous liposuction procedure. Secondly, ADSCs eliminate ethical concerns associated with the usage of embryonic stem cells because they can be derived from autologous fat (Cawthorn et al. 2012) .
In the light of increasing aging population worldwide, people are more susceptible to the musculoskeletal disorders such as osteoarthritis (OA), rheumatoid arthritis (RA), low back pain (LBP) and neck pain (NP) (Woolf 2015) . Osteoarthritis, the most common form of arthritis, involves inflammation and major structural changes of the joint which causes pain and functional disability (Cross et al. 2014) . As a result, enormous costs for health and social care systems are involved in managing osteoarthritis patients. In Asia, it has been estimated that the percentage of people aged 65 years will increase from 6.8% in 2008 to 16.2% in 2040 (Fransen et al. 2011) . Since OA has a strong relationship with ageing, the above-mentioned figure is of concern as it is indirectly reflected the impairment of life quality among the elderly affected with osteoarthritis. Furthermore, the recovery of cartilage lesion in osteoarthritis remains challenging because cartilage tissue has a very limited capacity for intrinsic healing. This is due to poor vascularisation, low chondrocyte density and poor mobility of chondrocytes (Wang et al. 2017) .
Autologous chondrocytes implantation (ACI) is a procedure that has shown promising outcomes for articular cartilage regeneration in early clinical studies (Breinan et al. 1997; Nehrer & Minas 2000) . For ACI, autologous chondrocytes are harvested arthroscopically from nonweight-bearing area of the articular cartilage and grown in monolayer cell culture to larger numbers in vitro. Once sufficient numbers are reached, cultured chondrocytes suspension is injected into the articular defect which is then covered by a periostal flap or collagen membrane (Afizah et al. 2007 ). The effectiveness of ACI have been shown previously by a long-term study of Brittberg et al. (1994) and Brittberg (1999) and this procedure can be modified with incorporation of biodegradable material with autologous chondrocytes in vitro before being implanted to the patients. Despite the clinical effectiveness of ACI, the procedure has been associated with significant donor-site morbidity, a slow rate of chondrocyte proliferation (Nejadnik et al. 2010) and difficulty in obtaining an adequate number of chondrocytes. To achieve a sufficient number of chondrocytes for ACI, the cells need to be expanded in a monolayer condition. However, chondrocytes that are released from the cartilage matrix and placed in monolayer culture dedifferentiate to fibroblast-like state and have a tendency to lose their chondrocyte-specific phenotypes (Benya & Shaffer 1982; Domm et al. 2002; Schnabel et al. 2002) . Dedifferentiation of chondrocyte in monolayer culture is accompanied by morphological changes and collagen expression profiles (Fuss et al. 2000; Stewart et al. 2000) and can occur as early as in the first passage (Schulze-Tanzil et al. 2002) . This occurrence may limit the chondrocyte expansion and proliferation in an attempt to treat big lesions through ACI procedure.
Previous studies have proven that co-culture technique may provide environment that is necessary for stem cell differentiation and promote chondrocyte proliferation. The studies have primarily utilised bone marrow derived stem cells and to a lesser extent, adipose-derived stem cell (Waters et al. 2013) . In most cases, 10% FBS along with growth factors including transforming growth factor (TGF) β1 and β3, basic fibroblast growth factor (bFGF), bone morphogenic protein-6 (BMP-6), dexamethasone were supplemented in the growth media during cell culturing to enhance chondrogenic differentiation (Bahney et al. 2011; Waters et al. 2013 ). However, little is known about the potential of ADSCs in co-culture environment to replace FBS as a source of growth factors to promote cell proliferation of chondrocyte in vitro.
In the present study, chondrocytes and adipose derived stem cells (ADSCs) with 1:1, 1:2 and 2:1 ratio were cocultured in order to evaluate if ADSCs could replace FBS as growth factor in culturing medium. The aim of this study was to answer the following research questions: Can ADSCs replace FBS as commonly used growth factors and lead to increase proliferation of chondrocytes in coculture system? Do different co-cultures ratio of ADSCs and chondrocyte influence cell proliferation and chondrogenic markers expression? The outcome of this study should provide a better understanding of the effect of ADSCs in chondrogenic co-culture system in minimal effect of FBS as a strategy to improve proliferation of chondrocytes in vitro towards clinical application.
MATERIALS AND METHODS ETHICS STATEMENT
Abdominal subcutaneous tissue was collected from consented patient undergoing caesarean section in the Department of Obstetrics and Gynaecology, Universiti Kebangsaan Malaysia Medical Centre. Cartilage was collected from patients undergoing nasal septoplasty procedure in the Department of Otorhinolaryngology, Universiti Kebangsaan Malaysia Medical Center. Sample collection and research protocols were reviewed and approved by the Universiti Kebangsaan Malaysia Medical Research and Ethics committee (FF-068-2013) .
ISOLATION OF ADIPOSE DERIVED STEM CELLS (ADSCS) ISOLATION
Adipose tissue was collected in a sterile container and processed for stem cell isolation within 30 min of sample collection. Tissues were washed three times with phosphate-buffered saline (PBS; pH7.2; Invitrogen, Grand Island, USA) and minced into smaller pieces. The tissue was digested in 0.3% collagenase type I (Worthington, Lakewood, NJ) and placed in orbital shaker at 37 o C with continuous agitation. After centrifugation, the supernatant containing mature adipocytes, was discarded and the cell pellet was suspended in culture medium (Ham's F12: Dulbecco's Modified Eagle Medium (F12: DMEM) supplemented with 10% FBS (Invitrogen), 1% Vitamin C (Sigma, St. Louis, MO) 1% antibiotic-antimycotic (Invitrogen), 1% Glutamax (Invitrogen) and plated immediately in T25 flasks. This initial passage of the primary cell culture was referred to as passage 0 (P0).
Cultures were maintained in an incubator with 5% CO 2 at 37°C. Cells were passaged repeatedly after achieving a density of 75%-90% (approximately 4 days in culture) until passage 4.
FLOW CYTOMETRY ANALYSIS
For ADSCs characterisation, cell surface antigen phenotyping was performed on ADSCs at passage 4. The cells were incubated with anti-human antibodies: CD9-phycoerythrin (PE), CD34-fluorescein isothiocyanate (FITC), CD117-PE, CD31-PE, CD44-FITC, CD-45-FITC, CD73-FITC, CD90-FITC, HLA ABC-FITC and HLA DP-DQ-DR-FITC (BD Biosciences, NJ, USA). Approximately 10,000 labeled cells were acquired for each surface marker and the data were analyzed using CELLQuestPro acquisition software (BD Bioscience, Franklin Lakes, NJ, USA).
ISOLATION OF CHONDROCYTES
The collected cartilage was cleaned by removing the adhering soft connective tissue and bone segment using phosphate buffer saline (PBS). Then, the cartilage was minced into smaller pieces and placed in 0.6% Collagenase Type II buffer for 3-4 h in a 37 o C shaker incubator. Subsequently, the cell pellet was harvested after repeated centrifugation and rinsed with PBS. Finally, the pellet was suspended in Ham's F12: Dulbecco's Modified Eagle Medium (F12:DMEM) supplemented with 10% FBS and 2 μL of Insulin Transferrin Selenium (ITS) and transferred into a 6-well plate. The culture was maintained in a humidified incubator with 5% CO 2 at 37°C. After reaching 90% confluence, the primary culture (P0) was trypsinised using 0.125% trypsin-EDTA and passaged at a culture expansion ratio of 1:3 until passage 1 (P1).
CELL LABELLING
To observe the morphological features of the cells, chondrocytes and adipose derived stem cells were detached using 0.125% Tripsin EDTA and 1.5 uL of 10 mM CellTracker™ (Invitrogen) dye, CellTracker™ Green CMFDA (5-chloromethylfluorescein diacetate) for chondrocytes and CellTracker™ Red CMTPX for hADSCs were added.
CO-CULTURE OF ADSCS WITH CHONDROCYTES
ADSCs and chondrocytes were seeded onto a 24-well plate at a respective ratio ( To determine total cell number all co-cultures group were trypsinised using 0.125% Trypsin EDTA and the cell number were determined using haemacytometer and Trypan Blue dye exclusion.
QUANTITATIVE GENE EXPRESSION ANALYSIS BY REAL-TIME POLYMERASE CHAIN REACTION (qPCR)
To determine the mRNA expression of chondrogenic and stem cell associated markers, the cDNA was subjected to quantitative PCR analysis using IQ TM SYBR ® Green Supermix (Bio-Rad, Hercules,CA). The sets of primer used to study the gene of interest were Collagen Type II (Col II), Aggrecan Core Protein (ACP), Nanog homeobox pseudogene 3 (Nanog3), Octamer Binding Protein (Oct-4) and Fibroblast Growth Factor (FGF-4) ( Table 1) . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH was used as the housekeeping gene to normalise the data. The specific primers were designed using Primer 3 software according to published GeneBank database sequences. The quantitative PCR reaction was performed using SYBR Green as a dye to detect PCR products in BioRad iCycler PCR machine. The reaction mixture consisted of iQ SYBR Supermix, forward and reverse primers (500 nM each), deionised water and the respected cDNA. The reactions were performed under following conditions:
Cycle 1:
Step 1 95°C for 3 min (1 time), cycle 2:
Step 1 95°C for 10 s and Step 2 61 o C for 30 s (40 times), cycle 3:
Step 1 95°C for 1 min (1 time), cycle 4:
Step 1 55°C for 1 min (1 time) and cycle 5:
Step 1 60°C for10 s (70 times). To verify the specificity of each PCR product, gel electrophoresis analysis was performed. Each PCR products was subjected to 2% agarose (Invitrogen, Carlsbad, CA, USA) gel electrophoresis stained with ethidium bromide (Sigma-Aldrich, St. Louis, MO, USA) and visualised using UV transillumination (Vilber Lourmat, Marne La Vallee, France).
STATISTICAL ANALYSIS
Data were analysed using SPSS 15.0 (SPSS Inc. Chicago, IL, USA) and presented as mean + standard error of mean (SEM) and standard deviation (SD). One-way ANOVA statistical analysis was performed using GraphPad Prism version 7 (La Jolla California USA) and a difference at the 5% level was considered as a statistically significance. (Hui et al. 2012) , bone marrow derived stem cell growth (Shahdadfar et al. 2005 ) and promote engraftment after allogenic transplantation of human peripheral blood haematopoetic stem cells in NOD/SCID mice (Kim et al. 2005 ). In our study, ADSCs is characterised by flow cytometry analysis. ADSCs displayed positive staining for stromal associated markers (CD90-99.9%, CD73-99.7%, CD44-99.4%), stem cell adhesion molecule (CD9-91.2%) and MHC class I (HLA ABC-91.2%). On the contrary, ADSCs lacking expression of haematopoietic markers (CD31-1.9%, CD45-6.3%), stem cell factor (CD117-2.4%) and histocompatibility antigen class II (HLA DP-DQ-DR-3.0%).
EFFECTS OF CO-CULTURE OF ADSCS WITH CHONDROCYTES ON CELL PROLIFERATION
The results from our study indicated that, the co-culture of chondrocytes with ADSCs promoted cell proliferation in all co-culture ratio groups as compared to the chondrocytes alone. On day 5 of culture, the cell numbers were significantly higher in all ADSCs and chondrocyte co-culture groups as compared to ADSCs and chondrocytes alone. The cells showed highest proliferation in co-culture group of 1:1 and 1:2. While the co-culture group showed the least cell proliferation was in group of 2:1. Statistical analysis showed significant difference of cell proliferation between the co-culture groups of 1:1, 1:2 and 2:1 when compared with control groups (chondrocytes and ADSCs) (p<0.05). However, there was no significant difference in the cell proliferation between all co-culture groups (Figure 2) . The effects might be due to soluble factors, VEGF, HIF-1α, IGF-1 and fibroblast growth factor that were secreted by ADSC as confirmed by a previous study (Zhong et al. 2016 ).
Using co-culture model, Kim et al. (2007) reported that ADSCs promoted human dermal fibroblast proliferation by cell-to cell contact as well as paracrine activation. One dimensional gel electrophoresis combined with tandem mass spectrometry analysis showed that ADSCs secreted growth factors, collagen and fibronectin that are important for cell growth and proliferation (De Lany et al. 2005; Kratchmarova et al. 2002) . Findings from these studies were in consistent with the term 'trophic' that has been introduced by Caplan and Dennis (2006) in describing the factors secreted by mesenchymal stem cells. This term is also associated with the effect of the factors produced by mesenchymal cells in supporting in the proliferation and matrix production of neighbouring cells.
EFFECT OF CO-CULTURE OF ADSCS WITH CHONDROCYTE ON CHONDROGENESIS AND STEMNESS GENE EXPRESSION
Despite the suggested trophic effect of ADSCs that helps in cell proliferation, we did not exclude the possible influence of chondrocytes in promoting ADSCs differentiation. under inverted and fluorescence microscope on day 1, 3 and 5 (Figures 2-5) . In a monolayer culture, ADSCs exhibit fibroblastic-shape feature while chondrocytes exhibit polygonal-shaped throughout day 1, 3 and 5 of culture (Figures 2 & 3) . In co-culture groups with a ratio of 1:1 and 1:2, some of the ADSCs that were initially spindle shape (red-stained) have changed into polygonal shaped cells. These morphological changes can be particularly seen at day 3 and 5 in the co-culture group with a ratio of 1:1 and 1:2 ( Figure 5 ). The morphological changes were accompanied by expression of chondrogenic specific markers (Collagen Type II and ACP) in all co-culture groups. In order to assess the effect of co-culture ratios on mRNA expression level of chondrogenic markers, qPCR was performed on Collagen Type II and Aggrecan core protein (ACP). Cells cultured in a co-culture group expressed chondrogenic specific marker, Col II and ACP at day 5. Between all co-culture groups, group with a ratio of 1:1 showed higher expression of Collagen Type II while group with a ratio of 1:2 showed higher expression of ACP. However, there was no statistically difference of Collagen Type II and ACP expression between all co-culture groups (1:1, 1:2, 2:1) with control (chondrocytes) (Figure 6 ). Collagen Type II and aggrecan are specific markers for regenerated cartilage (Anderer & Libera 2002; Schulzetanzil 2009 ) and the expression of these markers are significant to differentiate between hyaline cartilage and fibrocartilage. Fibrocartilage may function satisfactorily in cartilage repair for a certain period of time, however it does not exhibit normal articular material property. As a result, the repair will be less durable to withstand loading than normal articular cartilage (Frenkel SR & Di Cesare 1999) . Our results indicated that chondrocytes may exert some effects in promoting chondrogenic differentiation of ADSCs. Previous studies done using mesenchymal stem cells showed similar results when mesenchymal stem cells were cultured together with chondrocytes (Yang et al. 2012; Xu et al. 2013 ). Interestingly, co-culture group cells also expressed stem cell associated markers, Oct-4, Nanog and FGF-4. In all co-culture groups, the expression of Oct-4, FGF-4, and Nanog were relatively low as compared to ADSCs alone ( Figure 6 ). The expression of stem cell associated markers gave the implication that there was still stemness property exhibited by ADSCs although in a co-cultured environment that favours chondrogenesis. We believed with the extension of culturing period, there was a possibility that the remaining ADSCs in the co-culture could be differentiated into chondrogenic lineage. But the most important part that contributed to the success of the co-culture system is the ideal ratio of both cells. An ideal ratio should yield high quality cartilage as well as to minimize the usage of fetal bovine serum in cultures. In the present data, group ratio of 1:1 (ADSCs: chondrocytes) has greater effect on cell proliferation and chondrogenic gene expression as compared to other groups. Viable chondrocyte is very difficult to be obtained from the patient cartilage and if successful, only a small number of chondrocyte can be harvested. In the ratio of 1:1 (ADSCs: chondrocytes), less number of chondrocytes is needed to start the culture. Although a ratio of co-culture 1:2 showed almost similar outcome, there was possibility that the expression of high stemness marker as indicated in FGF-4 expression might hinder the chondrogenesis of ADSCs in co-culture system.
CONCLUSION
Our data suggested that chondrogenesis of ADSCs by coculture with chondrocytes in low serum is an appropriate strategy to provide chondrogenic cells for treating cartilage lesion in the clinical setting. This in view with the cell proliferation ability of the co-culture cells, the chondrogenic differentiation evidences, serum low dependency as well as animal serum substitution with an autologous patient's serum.
